James Edward Doyle, Director at EXACT SCIENCES CORP (EXAS), sold 2,000 shares at $97.42 ($195K) on 2023-07-27, disclosed to the SEC on 2023-07-28.
Scheduled sale ($195k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EXAS | SELL | 2024-03-04 | $115K | — | Filing → |
| EXAS | SELL | 2023-06-12 | $254K | — | Filing → |
| EXAS | SELL | 2023-05-31 | $161K | — | Filing → |